Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kanjanapan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Internal Medicine Journal|November 19, 2013
Denosumab-induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failureN Farinola, Y Kanjanapan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Novel patterns of response under immunotherapyE Borcoman, Y Kanjanapan, S Champiat, et al.
Internal Medicine Journal|August 11, 2016
Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinomaD Day, Y Kanjanapan, E Kwan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Internal Medicine Journal|November 19, 2013
Denosumab-induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failureN Farinola, Y Kanjanapan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Novel patterns of response under immunotherapyE Borcoman, Y Kanjanapan, S Champiat, et al.
Internal Medicine Journal|August 11, 2016
Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinomaD Day, Y Kanjanapan, E Kwan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Pageof 1